The Cancer Letter Archives
The Cancer Letter was founded in 1973, two years after Congress passed the National Cancer Act of 1971. These archives represent the first 40 years of The Cancer Letter, which is published weekly.
TCL
Vol.
34
No.
03
January 25, 2008
CCL
Vol.
31
No.
1
January 25, 2008
- Early, Short Course Of Hormonal Therapy May Allow Patients To Live Longer
- High-Dose Chemo, Stem Cell Transplant No Benefit For Node+ Breast Cancer
- Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer
- Longterm Followup Finds Taxotere Improves Survival
- Drug Combination Tested For B.C. Brain Metastases
- Sunitinib May Be Associated With Cardiac Toxicity
- BRCA Carriers Live Longer Than Those With Normal Gene
- Rev/Vel/Dex Response Rate High In Phase I/II Study
- FDA Approves Genetic Test For Breast Cancer Patients
- NCI Cooperative Group, Cancer Center Trials Listed
TCL
Vol.
34
No.
05
February 08, 2008